Avient Corporation today announced the expansion of its bio-based polymer solutions for medical and pharmaceutical applications PARIS – May 18, 2022 – Avient Corporation, a premier provider of specialized and sustainable material solutions and services, today announced expansion of its line of bio-based Mevopur™ medical-grade polymer solutions. Media contact:  Scott Collins  scollins@collins-marcom.com  +1 216.382.8840  

Avient Announces Quarterly Dividend... Avient Board of Directors Appoints Ashish K. Avient Announces First Quarter 2025 Results...

From streamlining design, manufacturing and supply chain processes, to navigating regulatory demands, we’ll help you optimize the performance of your medical equipment, so you can grow your bottom line and stand apart from your competition. In addition to maintaining an effective manufacturing and supply chain operation, you’re challenged with designing products that must meet strict regulatory and quality assurance standards. At Avient Distribution, we help you achieve these goals with our comprehensive portfolio of leading suppliers, on-time delivery and a host of services focused on helping you succeed.

Avient Canada ULC Avient Supplier Information Supplier Code of Conduct

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

Hydrocerol™ Chemical Foaming Agents are supplied as concentrates and are added to virgin or recycled polymer during the plastic conversion process. They can also be part of the chemical foaming process, achieving a material expansion of up to 50%. Avient makes no warranties or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens

Office Supplies Pet Care & Supplies Auto-injectors and Drug Delivery Pens